Solid Biosciences (SLDB) Retained Earnings (2017 - 2026)
Solid Biosciences (SLDB) reported Retained Earnings of -$1.0 billion for Q1 2026, down 50725700.0% on a YoY basis from N/an in Q1 2025, and down 1951084.62% sequentially from $52000.0 in Q4 2025.
Solid Biosciences (SLDB) Retained Earnings (2017 - 2026) Analysis & Trends
Solid Biosciences (SLDB) has 10 years of Retained Earnings data on file, last reported at -$1.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 50725700.0% year-over-year to -$1.0 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.0 billion (down 50725700.0% YoY), and the FY2025 full-year result was $52000.0, up 100.01% from the prior year.
- Retained Earnings eased to -$1.0 billion in Q1 2026, from $52000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $52000.0 in Q4 2025 to a low of -$1.0 billion in Q1 2026.
- A 5-year average of -$342.5 million and a median of -$68000.0 in 2022 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings soared 150.0% in 2025 and plunged 50725700.0% in 2026, its largest moves.
- Tracing SLDB's Retained Earnings over 5 years: stood at -$68000.0 in 2022, then soared by 122.06% to $15000.0 in 2023, then tumbled by 5223100.0% to -$783.4 million in 2024, then surged by 100.01% to $52000.0 in 2025, then slumped by 1951084.62% to -$1.0 billion in 2026.
- Business Quant data shows SLDB's Retained Earnings at -$1.0 billion in Q1 2026, $52000.0 in Q4 2025, and -$908.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Solid Biosciences | 529.40 Mn | 529.40 Mn | - | -1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.01 Bn |
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | -907.99 Mn |
| Jun 30, 2025 | -38,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -783.45 Mn |
| Sep 30, 2024 | -740.85 Mn |
| Jun 30, 2024 | -708.10 Mn |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 14,000.00 |
| Mar 31, 2023 | -592.81 Mn |
| Dec 31, 2022 | -68,000.00 |
| Sep 30, 2022 | -547.59 Mn |
| Jun 30, 2022 | -527.18 Mn |
| Mar 31, 2022 | -51,000.00 |
| Dec 31, 2021 | -476.76 Mn |
| Sep 30, 2021 | -458.15 Mn |
| Jun 30, 2021 | -11,000.00 |